Skip to content
Home/Companies/Pharma/Nuclidium AG

Nuclidium AG

Pharma·Switzerland·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Nuclidium AG?

Nuclidium AG is a Swiss Pharma company, currently owned by Bayern Kapital since 2025.

Hand-verified · updated 2026-08-10

Open JSON · CC-BY
Bayern Kapital
Investor
Bayern Kapital
Seedfonds Bayern · 1996 · VC

Key facts

HQSwitzerland
SectorPharma
StatusActive

More from Seedfonds Bayern

Other portfolio companies in the same fund.

Constellr
Constellr
Active
Aerospace & DefenceGermany· 2026
encosa
encosa
Active
ClimateTechGermany· 2026
Ewigbyte
Ewigbyte
Active
Deep TechGermany· 2026
Exergy3
Active
ClimateTechUK· 2026
NanoStruct
NanoStruct
Active
Deep TechGermany· 2026
Nature Robots
Active
AgTechGermany· 2026

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Nuclidium AG?

Nuclidium AG is currently owned by Bayern Kapital, through Seedfonds Bayern, since 2025.

When did Bayern Kapital acquire Nuclidium AG?

Bayern Kapital acquired Nuclidium AG in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue